These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 2909456

  • 21. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P.
    J Clin Oncol; 2003 Jun 01; 21(11):2115-22. PubMed ID: 12775737
    [Abstract] [Full Text] [Related]

  • 22. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
    Schlembach PJ, Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD.
    Int J Radiat Oncol Biol Phys; 2000 Nov 01; 48(4):1107-10. PubMed ID: 11072169
    [Abstract] [Full Text] [Related]

  • 23. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
    Oguchi M, Ikeda H, Isobe K, Hirota S, Hasegawa M, Nakamura K, Sasai K, Hayabuchi N.
    Int J Radiat Oncol Biol Phys; 2000 Aug 01; 48(1):161-8. PubMed ID: 10924986
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Primary gastrointestinal non-Hodgkin's lymphoma: treatment outcome.
    Al-Shemmari SH, Sajnani KP, Ameen RM, Ragheb AM.
    Clin Lymphoma; 2003 Sep 01; 4(2):99-103. PubMed ID: 14556681
    [Abstract] [Full Text] [Related]

  • 26. Non-Hodgkin's lymphoma in Saudi Arabia: prognostic factors and an analysis of the outcome of combination chemotherapy only, for both localized and advanced disease.
    Ibrahim EM, Satti MB, Al-Idrissi HY, Al-Mulhim FA, Abssod GH, Abdel Jabar A.
    Eur J Cancer Clin Oncol; 1988 Mar 01; 24(3):391-401. PubMed ID: 2454821
    [Abstract] [Full Text] [Related]

  • 27. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 28. [Case histories of extranodal non-Hodgkin's lymphomas with primary gastrointestinal appearance].
    Buda F, Buda C, La Torre F, Simon G, Binotto F, Bellomo R, Russo F, Croatto T, Duchi M, Mandoliti G.
    Minerva Chir; 1993 Apr 15; 48(7):325-30. PubMed ID: 8327178
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).
    Economopoulos T, Fountzilas G, Kostourou A, Daniilidis J, Pavlidis N, Andreopoulou H, Nicolaou A, Papageorgiou E, Mellou S, Dervenoulas J, Stathakis N.
    Anticancer Res; 1998 Apr 15; 18(6B):4655-60. PubMed ID: 9891536
    [Abstract] [Full Text] [Related]

  • 32. Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience.
    Tondini C, Giardini R, Bozzetti F, Valagussa P, Santoro A, Bertulli R, Balzarotti M, Rocca A, Lombardi F, Ferreri AJ.
    Ann Oncol; 1993 Dec 15; 4(10):831-7. PubMed ID: 8117602
    [Abstract] [Full Text] [Related]

  • 33. A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G, De Souza C, Aversa S, Patti C, Tedeschi L, Candela M, Olivieri A, Chisesi T, Rubagotti A, Centurioni R, Nardi V, Congiu M, Gennaro M, Truini M, Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
    Braz J Med Biol Res; 2004 May 15; 37(5):719-28. PubMed ID: 15107935
    [Abstract] [Full Text] [Related]

  • 34. Localized stage I-IE aggressive non-Hodgkin's lymphoma (NHL): results of prospective study with multimodality therapeutic approach.
    De Sanctis V, Martelli M, Anticoli AP, Caronna R, Chirletti P, Giovannini M, Santarelli M, Enrici RM, Mandelli F.
    Anticancer Res; 2001 May 15; 21(6A):4169-72. PubMed ID: 11911313
    [Abstract] [Full Text] [Related]

  • 35. [Chemotherapy and radiotherapy for non-Hodgkin's lymphomas of the nasal cavity].
    Nie DH, Hu WH, Gao YH, Wu Y, Zhang SP.
    Zhonghua Zhong Liu Za Zhi; 2004 May 15; 26(5):312-4. PubMed ID: 15312373
    [Abstract] [Full Text] [Related]

  • 36. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
    Hagenbeek A, Carde P, Meerwaldt JH, Somers R, Thomas J, De Bock R, Raemaekers JM, van Hoof A, De Wolf-Peeters C, van Glabbeke M.
    J Clin Oncol; 1998 Jan 15; 16(1):41-7. PubMed ID: 9440721
    [Abstract] [Full Text] [Related]

  • 37. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study.
    Yahalom J, Varsos G, Fuks Z, Myers J, Clarkson BD, Straus DJ.
    Cancer; 1993 Apr 01; 71(7):2342-50. PubMed ID: 8453557
    [Abstract] [Full Text] [Related]

  • 38. [Prognostic factors in low-grade lymphoma].
    Gandarillas MA, Conde E, Mazorra F, Cuadrado MA, Baro J, Garijo J, Recio M, Richard C, Iriondo A, Zubizarreta A.
    Sangre (Barc); 1998 Jun 01; 43(3):185-90. PubMed ID: 9741223
    [Abstract] [Full Text] [Related]

  • 39. Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphoma.
    O'Connell MJ, Harrington DP, Earle JD, Johnson GJ, Glick JH, Neiman RS, Silverstein MN.
    Cancer; 1988 May 01; 61(9):1754-8. PubMed ID: 3128397
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.